Enregistrement - Lobbyistes salariés d'organisations

Objets

• Agriculture
• Budget
• Commerce international
• Développement économique
• Emploi et formation
• Énergie
• Environnement
• Foresterie
• Immigration
• Impôts et finances
• Industrie
• Marchés publics
• Pêches
• Petites entreprises
• Propriété intellectuelle
• Questions touchant les consommateurs
• Recherche et développement
• Relations internationales
• Santé
• Sciences et technologies

Détails sur l'objet

Politique ou Programme

• ACCESS & BENEFIT SHARING: TRIPS AGREEMENT in respect of protecting intellectual property and preventing increased uncertainty
• ADVENTITIOUS PRESCENCE POLICY in respect of new agricultural biotechnology products
• BIOSAFETY PROTOCOL in respect of Canada's participation in global discussions to ensure an enabling environment for safe new technologies
• Clarify the administration of SR&ED program to ensure clinical trials and international research conducted in Canada qualifies as eligible expenses
• Creation of a modern policy environment that recognizes international standards and reviews, and establishes clarity on data ownership for intellectual property
• Establish accountability with the federally financed Canadian Agency for Drugs and Technologies and Health (CADTH) and its Common Drug Review process (Health Canada)
• FOOD LABELLING in respect of mitigating the unnecessary introduction of new labelling requirements for products already approved under current regulated process and in respect of maintaining harmonization of requirements with trading nations
• IMPROVED TAXATION & INVESTMENT FRAMEWORK in respect of extending Canada's flow-through shares program to biotechnology companies for increased domestic investments.
• IMPROVEMENTS TO THE Scientifc Research & Experimental Development TAX CREDITS in respect of updating the 20 yr old system by removing the punitive Canadian Controlled Private Companies restriction and increasing the expenditure limit for refundable credits
• NOVEL FOODS in respect of maintaining a science-based regulatory system for novel foods derived from plant and animal biotechnology
• PATENTED MEDECINES PRICES REVIEW BOARD (PMPRB) PRICE REVIEW to ensure new guidelines and directives do not create disincentives for the introduction of new treatments in Canada
• RESEARCH & DEVELOPMENT (R&D) in respect on providing input to the government's expert panel on business R&D to improve incentives for research in Canada
• SCIENCE & TECHNOLOGY STRATEGY in respect of encouraging a strong government focus to stimulate the development, use and retention of biotechnology products, processes and companies
• SUBMISSION REVIEW PROCESS FOR BIOLOGICS, COST RECOVERY REVIEW to ensure Canada remains competitive overall and any new costs do not put bioloigics are a comparative disadvantage
• Vaccine Funding - National Immunization Strategy - to re-establish federal leadership in providing provinces with funding for new vaccines under a renewed national immunization strategy framework
• Vaccine contracting and supply
• WORLD TRADE ORGANIZATION (WTO) in respect of Canada's contribution and participation to encourage a sound business climate and to faciliate Canada's access to European markets for genetically engineered agricultural and animal products

Politique ou Programme, Règlement

• INTELLECTUAL PROPERTY/PATENT POLICY AND REGULATIONS in respect of creating Canada as one of the world's most competitive jurisdictions in protecting IP (e.g., match level of European Union via CETA negotiations)
• ORPHAN PRODUCTS to establish formal regulations, policies or programs to encourage the research, development and introduction of new technologies to treat "orphan" or neglected diseases
• REGULATORY APPROVAL PROCESS FOR PLANTS WITH NOVEL TRAITS as NOVEL FOODS or INDUSTRIAL BIO_PRODUCTS in respect of an efficient science-based approach and allows for greater cooperation among and between government departments
• Regulatory framework for subsequent entry biologics to ensure an appropriate and transparent appraoch for the safe introduction of biosimilars

Proposition législative, Projet de loi ou résolution, Règlement

• CANADIAN ENVIRONMENTAL PROTECTION ACT AND REGULATIONS in respect of modern, science-based regulations to reflect rapidly changing new technologies
• FOOD AND DRUGS ACT AND REGULATIONS in respect of minimizing regulatory burden and ensuring appropriate climate for the introduction of new technologies

Règlement

• SUBSEQUENT ENTRY BIOLOGICS to establish formal regulations to prescribe the requirements for introduction of biosimilars and ensure the protection of intellectual property for first entry biologics

Techniques de communication

• Communication écrite
• Communication orale
• Appel au grand public

Institutions gouvernementales

• Affaires mondiales Canada (AMC)
• Agence canadienne d'inspection des aliments (ACIA)
• Agence de la santé publique du Canada (ASPC)
• Agence de promotion économique du Canada atlantique (APECA)
• Agence du revenu du Canada (ARC)
• Agence fédérale de développement économique pour le Sud de l'Ontario (FedDev)
• Agriculture et Agroalimentaire Canada (AAC)
• Banque de développement du Canada (BDC)
• Bureau du Conseil privé (BCP)
• Cabinet du Premier ministre (CPM)
• Chambre des communes
• Conseil d'examen du prix des médicaments brevetés (CEPMB)
• Conseil de recherches en sciences humaines (CRSH)
• Conseil de recherches en sciences naturelles et en génie (CRSNG)
• Conseil national de recherches (CNRC)
• Développement économique Canada pour les régions du Québec
• Emploi et Développement social Canada (EDSC)
• Environnement et Changement climatique Canada (ECCC)
• Exportation et développement Canada (EDC)
• Finances Canada (FIN)
• Immigration, Réfugiés et Citoyenneté Canada (IRCC)
• Innovation, Sciences et Développement économique Canada (ISDE)
• Instituts de recherche en santé du Canada (IRSC)
• Office d'investissement du régime de pensions du Canada
• Pêches et Océans Canada (MPO)
• Ressources naturelles Canada (RNCan)
• Santé Canada (SC)
• Secrétariat du Conseil du Trésor du Canada (SCT)
• Sénat du Canada
• Statistique Canada (StatCan)

Adresse :
600 - 1 NICHOLAS STREET
OTTAWA, ON  K1N 7B7
Canada

Numéro de téléphone : 613-230-5585  Poste 229
Numéro de fax : 613-563-8850